Tae-Ho Jang

Title: Tae-Ho Jang: Innovator in Cancer Treatment

Introduction

Tae-Ho Jang is a prominent inventor based in Gyeongsan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for cancer treatment. His innovative work focuses on creating effective therapeutic agents that can combat various forms of cancer.

Latest Patents

Tae-Ho Jang holds a patent for an imidazopyridine derivative, which is a method for preparing the compound and a pharmaceutical composition containing it as an active ingredient for preventing or treating cancer. This invention relates to a novel imidazopyridine derivative that effectively inhibits cancer-related kinases. The compound has shown excellent results in inhibiting the proliferation of cancer cells in both cancer cell lines and heterograft models. Additionally, it has been confirmed to be useful in treating diabetic nephropathy in animal model experiments.

Career Highlights

Tae-Ho Jang is associated with the Daegu-Gyeongbuk Medical Innovation Foundation, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding innovative solutions to pressing medical challenges, particularly in oncology.

Collaborations

Tae-Ho Jang collaborates with notable colleagues, including Hwan Geun Choi and Jung Beom Son. These partnerships enhance the research and development process, allowing for a multidisciplinary approach to tackling complex medical issues.

Conclusion

Tae-Ho Jang's contributions to the field of cancer treatment through his innovative patent demonstrate his dedication to improving patient outcomes. His work not only addresses the challenges of cancer but also opens new avenues for research in related diseases.